Research Overview

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on technology platforms that leverage AI and ML algorithms for novel target discovery and drug development applications. A key focus of this issue is on precision oncology tests and other predictive genetic tests for multiple therapeutic applications. In particular, technologies which enable early diagnosis of cancers, support biomarker discovery and disease prognosis have been covered. Another focus of this issue is on advanced RNA therapeutics, including circular RNA and self-replicating RNAs which offer several advantages of conventional mRNA based therapeutics. In addition, advanced drug delivery using engineered cells and biosensors for monitoring therapy efficacy and response have been captured.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.